{
  "api_version": "1",
  "request": {
    "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=PE+-+Pulmonary+Embolism&page=2",
    "query": {
      "condition": "PE - Pulmonary Embolism",
      "page": 2
    },
    "page_size": 10
  },
  "pagination": {
    "page": 2,
    "page_size": 10,
    "total_count": 10,
    "total_pages": 1,
    "next_page_url": null,
    "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=PE+-+Pulmonary+Embolism&page=1&page_size=10"
  },
  "source": "remote",
  "last_synced_at": "2026-07-23T09:22:38.730Z",
  "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.",
  "notes": [
    "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.",
    "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.",
    "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees."
  ],
  "trials": [
    {
      "nct_id": "NCT03915925",
      "title": "Short-term Clinical Deterioration After Acute Pulmonary Embolism",
      "overall_status": "COMPLETED",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Pulmonary Embolism"
      ],
      "interventions": [],
      "intervention_types": [],
      "sponsor": "Wake Forest University Health Sciences",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 935,
      "start_date": "2018-09-30",
      "completion_date": "2020-11-30",
      "has_results": false,
      "last_update_posted_date": "2022-04-27",
      "last_synced_at": "2026-07-23T09:22:38.730Z",
      "location_count": 6,
      "location_summary": "San Diego, California • Newark, Delaware • Orlando, Florida + 3 more",
      "locations": [
        {
          "city": "San Diego",
          "state": "California"
        },
        {
          "city": "Newark",
          "state": "Delaware"
        },
        {
          "city": "Orlando",
          "state": "Florida"
        },
        {
          "city": "Charlotte",
          "state": "North Carolina"
        },
        {
          "city": "Nashville",
          "state": "Tennessee"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT03915925"
    },
    {
      "nct_id": "NCT00409136",
      "title": "Multi-Center Human Alert Trial to Prevent DVT and PE",
      "overall_status": "COMPLETED",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Pulmonary Embolism",
        "Deep Vein Thrombosis",
        "Cancer",
        "Surgery"
      ],
      "interventions": [
        {
          "name": "Human Alert",
          "type": "BEHAVIORAL"
        }
      ],
      "intervention_types": [
        "BEHAVIORAL"
      ],
      "sponsor": "Brigham and Women's Hospital",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 2496,
      "start_date": "2006-03",
      "completion_date": "2008-08",
      "has_results": false,
      "last_update_posted_date": "2009-02-02",
      "last_synced_at": "2026-07-23T09:22:38.730Z",
      "location_count": 26,
      "location_summary": "Scottsdale, Arizona • Long Beach, California • Orange, California + 22 more",
      "locations": [
        {
          "city": "Scottsdale",
          "state": "Arizona"
        },
        {
          "city": "Long Beach",
          "state": "California"
        },
        {
          "city": "Orange",
          "state": "California"
        },
        {
          "city": "Sacramento",
          "state": "California"
        },
        {
          "city": "Denver",
          "state": "Colorado"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT00409136"
    },
    {
      "nct_id": "NCT02476526",
      "title": "Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE4"
      ],
      "conditions": [
        "Chronic Kidney Disease",
        "Pulmonary Embolism",
        "Renal Artery Stenosis",
        "Pulmonary Cancer"
      ],
      "interventions": [
        {
          "name": "Low Volume iso-osmolar non-ionic radio contrast medium",
          "type": "DRUG"
        },
        {
          "name": "Acetylcysteine Inhalation",
          "type": "DRUG"
        },
        {
          "name": "Sodium Bicarbonate Solution",
          "type": "DRUG"
        },
        {
          "name": "64-MDCT Scanning",
          "type": "PROCEDURE"
        }
      ],
      "intervention_types": [
        "DRUG",
        "PROCEDURE"
      ],
      "sponsor": "VA Greater Los Angeles Healthcare System",
      "sponsor_class": "FED",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 50,
      "start_date": "2008-09",
      "completion_date": "2017-11-20",
      "has_results": false,
      "last_update_posted_date": "2017-11-28",
      "last_synced_at": "2026-07-23T09:22:38.730Z",
      "location_count": 1,
      "location_summary": "Los Angeles, California",
      "locations": [
        {
          "city": "Los Angeles",
          "state": "California"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT02476526"
    },
    {
      "nct_id": "NCT05568927",
      "title": "Validation of SEARCH, a Novel Hierarchical Algorithm to Define Long-term Outcomes After Pulmonary Embolism",
      "overall_status": "COMPLETED",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Pulmonary Embolism",
        "Chronic Thromboembolic Pulmonary Hypertension"
      ],
      "interventions": [
        {
          "name": "SEARCH algorithm",
          "type": "OTHER"
        }
      ],
      "intervention_types": [
        "OTHER"
      ],
      "sponsor": "University of California, San Diego",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 150,
      "start_date": "2022-11-15",
      "completion_date": "2025-06-13",
      "has_results": false,
      "last_update_posted_date": "2025-11-04",
      "last_synced_at": "2026-07-23T09:22:38.730Z",
      "location_count": 8,
      "location_summary": "Fresno, California • Irvine, California • Los Angeles, California + 5 more",
      "locations": [
        {
          "city": "Fresno",
          "state": "California"
        },
        {
          "city": "Irvine",
          "state": "California"
        },
        {
          "city": "Los Angeles",
          "state": "California"
        },
        {
          "city": "Moreno Valley",
          "state": "California"
        },
        {
          "city": "Sacramento",
          "state": "California"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT05568927"
    },
    {
      "nct_id": "NCT06451003",
      "title": "Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery",
      "overall_status": "RECRUITING",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Venous Thromboembolism",
        "Pulmonary Embolism",
        "Deep Vein Thrombosis",
        "Cancer",
        "Surgery"
      ],
      "interventions": [
        {
          "name": "Exposure to clinical decision support system and education",
          "type": "BEHAVIORAL"
        }
      ],
      "intervention_types": [
        "BEHAVIORAL"
      ],
      "sponsor": "Medical University of South Carolina",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 30,
      "start_date": "2024-07-01",
      "completion_date": "2026-12-31",
      "has_results": false,
      "last_update_posted_date": "2025-07-31",
      "last_synced_at": "2026-07-23T09:22:38.730Z",
      "location_count": 1,
      "location_summary": "Charleston, South Carolina",
      "locations": [
        {
          "city": "Charleston",
          "state": "South Carolina"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT06451003"
    },
    {
      "nct_id": "NCT04168203",
      "title": "Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE4"
      ],
      "conditions": [
        "Deep Vein Thrombosis",
        "Pulmonary Embolism",
        "Venous Thromboembolism"
      ],
      "interventions": [
        {
          "name": "Apixaban 2.5 MG",
          "type": "DRUG"
        },
        {
          "name": "Placebo oral tablet",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "Brigham and Women's Hospital",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 600,
      "start_date": "2021-03-01",
      "completion_date": "2025-04-08",
      "has_results": true,
      "last_update_posted_date": "2025-11-14",
      "last_synced_at": "2026-07-23T09:22:38.730Z",
      "location_count": 1,
      "location_summary": "Boston, Massachusetts",
      "locations": [
        {
          "city": "Boston",
          "state": "Massachusetts"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT04168203"
    },
    {
      "nct_id": "NCT05111613",
      "title": "The PEERLESS Study",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Pulmonary Embolism",
        "Pulmonary Thromboembolism"
      ],
      "interventions": [
        {
          "name": "Catheter-Directed Thrombolysis",
          "type": "DEVICE"
        },
        {
          "name": "FlowTriever System",
          "type": "DEVICE"
        }
      ],
      "intervention_types": [
        "DEVICE"
      ],
      "sponsor": "Inari Medical",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 692,
      "start_date": "2022-02-14",
      "completion_date": "2024-04-11",
      "has_results": true,
      "last_update_posted_date": "2025-11-13",
      "last_synced_at": "2026-07-23T09:22:38.730Z",
      "location_count": 56,
      "location_summary": "Loma Linda, California • Orange, California • Pasadena, California + 46 more",
      "locations": [
        {
          "city": "Loma Linda",
          "state": "California"
        },
        {
          "city": "Orange",
          "state": "California"
        },
        {
          "city": "Pasadena",
          "state": "California"
        },
        {
          "city": "Aurora",
          "state": "Colorado"
        },
        {
          "city": "Lakeland",
          "state": "Florida"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT05111613"
    },
    {
      "nct_id": "NCT00377091",
      "title": "Is Using Fondaparinux (Blood Thinner) to Treat Lung Clot Cheaper Than Traditional Therapy",
      "overall_status": "WITHDRAWN",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE4"
      ],
      "conditions": [
        "Pulmonary Embolism"
      ],
      "interventions": [
        {
          "name": "Fondaparinux",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "University of Minnesota",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 0,
      "start_date": "2007-06",
      "completion_date": "2007-11",
      "has_results": false,
      "last_update_posted_date": "2013-05-30",
      "last_synced_at": "2026-07-23T09:22:38.730Z",
      "location_count": 1,
      "location_summary": "Duluth, Minnesota",
      "locations": [
        {
          "city": "Duluth",
          "state": "Minnesota"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT00377091"
    },
    {
      "nct_id": "NCT03761173",
      "title": "FlowTriever All-Comer Registry for Patient Safety and Hemodynamics",
      "overall_status": "COMPLETED",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "PE - Pulmonary Embolism",
        "PE - Pulmonary Thromboembolism"
      ],
      "interventions": [
        {
          "name": "FlowTriever System",
          "type": "DEVICE"
        },
        {
          "name": "Anticoagulation Agents",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DEVICE",
        "DRUG"
      ],
      "sponsor": "Inari Medical",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 1200,
      "start_date": "2018-12-15",
      "completion_date": "2024-09-04",
      "has_results": true,
      "last_update_posted_date": "2025-10-01",
      "last_synced_at": "2026-07-23T09:22:38.730Z",
      "location_count": 59,
      "location_summary": "Birmingham, Alabama • Tucson, Arizona • Aurora, Colorado + 47 more",
      "locations": [
        {
          "city": "Birmingham",
          "state": "Alabama"
        },
        {
          "city": "Tucson",
          "state": "Arizona"
        },
        {
          "city": "Tucson",
          "state": "Arizona"
        },
        {
          "city": "Aurora",
          "state": "Colorado"
        },
        {
          "city": "New Haven",
          "state": "Connecticut"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT03761173"
    },
    {
      "nct_id": "NCT03271450",
      "title": "The DARE Warfarin CER Study",
      "overall_status": "UNKNOWN",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Deep Venous Thrombosis",
        "Pulmonary Embolism"
      ],
      "interventions": [
        {
          "name": "Dabigatran: extended treatment (e.g at least 90 days)",
          "type": "DRUG"
        },
        {
          "name": "Dabigatran: extended treatment (e.g at least 180 days)",
          "type": "DRUG"
        },
        {
          "name": "Dabigatran: extended treatment (e.g at least 270 days)",
          "type": "DRUG"
        },
        {
          "name": "Apixaban: extended treatment (e.g at least 90 days)",
          "type": "DRUG"
        },
        {
          "name": "Apixaban: extended treatment (e.g at least 180 days)",
          "type": "DRUG"
        },
        {
          "name": "Apixaban: extended treatment (e.g at least 270 days)",
          "type": "DRUG"
        },
        {
          "name": "Rivaroxaban: extended treatment (e.g at least 90 days)",
          "type": "DRUG"
        },
        {
          "name": "Rivaroxaban: extended treatment (e.g at least 180 days)",
          "type": "DRUG"
        },
        {
          "name": "Rivaroxaban: extended treatment (e.g at least 270 days)",
          "type": "DRUG"
        },
        {
          "name": "Edoxaban: extended treatment (e.g at least 90 days)",
          "type": "DRUG"
        },
        {
          "name": "Edoxaban: extended treatment (e.g at least 180 days)",
          "type": "DRUG"
        },
        {
          "name": "Edoxaban: extended treatment (e.g at least 270 days)",
          "type": "DRUG"
        },
        {
          "name": "Warfarin: extended treatment (e.g at least 90 days)",
          "type": "DRUG"
        },
        {
          "name": "Warfarin: extended treatment (e.g at least 180 days)",
          "type": "DRUG"
        },
        {
          "name": "Warfarin: extended treatment (e.g at least 270 days)",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "Brigham and Women's Hospital",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 416000,
      "start_date": "2017-07-01",
      "completion_date": "2021-10-30",
      "has_results": false,
      "last_update_posted_date": "2021-06-23",
      "last_synced_at": "2026-07-23T09:22:38.730Z",
      "location_count": 1,
      "location_summary": "Boston, Massachusetts",
      "locations": [
        {
          "city": "Boston",
          "state": "Massachusetts"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT03271450"
    }
  ]
}